Drugs / Conventional MTA
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT06219824 Comparator | Nov 2024 → Nov 2025 overdue | dental caries, dental pulp disorder | Cairo University | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Conventional MTA | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06219824 ↗ |
| Modality | Other / unclassified | “conventional powder and liquid Mineral Trioxide Aggregate” NCT06219824 ↗ |